Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 25.01

-16.0%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roger A. Babb who wrote (2951)	6/11/1998 11:02:00 PM
From: gamesmistress	Read Replies (2) of 5736

OK, let's do some figgering. According to CCSI's rebuttal, they stated that 15,000,000 individual laboratory serum bilirubin tests were conducted in the US annually, and hospitals charged between $22-$34 per test for insurance reimbursement. This is where Asensio gets his statement that CCSI claims US hospitals spend approximately $330 to $510 million/year monitoring infant jaundice. I don't think you can assume that CCSI "must expect to sell it [the disposable device] for upwards of $20 to meet their $300 million market projection." Why wouldn't they price it aggressively - say less than half of the current price - in any country they chose to market it to? If an easy to use, inexpensive test is available the number of tests done may well increase. The test does not require a lab and can be done at home by non-professionals, I believe. I agree that in many countries births do not occur in hospitals and this sort of test could be popular if it's marketed well and priced right.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next